I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Tamada, Satoshi
194
results:
Online X
english X
Search for persons
X
Format
Online (194)
Mediatypes
Articles (Online) (131)
OpenAccess-fulltext (63)
Sorted by: Relevance
Sorted by: Year
?
1
Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitini..:
Plimack, Elizabeth R.
;
Powles, Thomas
;
Stus, Viktor
...
European Urology. 84 (2023) 5 - p. e123-e124 , 2023
Link:
https://doi.org/10.1016/..
?
2
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line ..:
Plimack, Elizabeth R.
;
Powles, Thomas
;
Stus, Viktor
...
European Urology. 84 (2023) 5 - p. 449-454 , 2023
Link:
https://doi.org/10.1016/..
?
3
Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitini..:
Plimack, Elizabeth R.
;
Powles, Thomas
;
Stus, Viktor
...
European Urology. , 2023
Link:
https://doi.org/10.1016/..
?
4
Final efficacy and safety results and biomarker analysis of..:
Nakaigawa, Noboru
;
Tomita, Yoshihiko
;
Tamada, Satoshi
...
International Journal of Clinical Oncology. 28 (2023) 3 - p. 416-426 , 2023
Link:
https://doi.org/10.1007/..
?
5
Prognostic value of PD-L1 expression in recurrent renal cel..:
Tamada, Satoshi
;
Nozawa, Masahiro
;
Ohba, Kojiro
...
International Journal of Clinical Oncology. 28 (2022) 2 - p. 289-298 , 2022
Link:
https://doi.org/10.1007/..
?
6
Pathologic complete response with pembrolizumab plus axitin..:
Shimizu, Kazuki
;
Tamada, Satoshi
;
Matsuoka, Yudai
...
International Cancer Conference Journal. 11 (2022) 3 - p. 205-209 , 2022
Link:
https://doi.org/10.1007/..
?
7
Health-related Quality of Life Analysis from KEYNOTE-426: P..:
Bedke, Jens
;
Rini, Brian I.
;
Plimack, Elizabeth R.
...
European Urology. 82 (2022) 4 - p. 427-439 , 2022
Link:
https://doi.org/10.1016/..
?
8
Phase I/II study of multipeptide cancer vaccine IMA901 afte..:
Hongo, Fumiya
;
Ueda, Takashi
;
Takaha, Natsuki
...
International Journal of Urology. 30 (2022) 2 - p. 176-180 , 2022
Link:
https://doi.org/10.1111/..
?
9
Lenvatinib plus pembrolizumab versus sunitinib for advanced..:
Eto, Masatoshi
;
Takagi, Toshio
;
Kimura, Go
...
Cancer Medicine. 12 (2022) 6 - p. 6902-6912 , 2022
Link:
https://doi.org/10.1002/..
?
10
Kamikihito improves cancer‐related fatigue in castration‐re..:
Tamada, Satoshi
;
Iguchi, Taro
;
Kato, Minoru
...
Traditional & Kampo Medicine. 8 (2021) 3 - p. 204-210 , 2021
Link:
https://doi.org/10.1002/..
?
11
Pembrolizumab plus axitinib versus sunitinib in metastatic ..:
Tamada, Satoshi
;
Kondoh, Chihiro
;
Matsubara, Nobuaki
...
International Journal of Clinical Oncology. 27 (2021) 1 - p. 154-164 , 2021
Link:
https://doi.org/10.1007/..
?
12
Myeloid-derived suppressor cells are essential partners for..:
Takeyama, Yuji
;
Kato, Minoru
;
Tamada, Satoshi
...
Cancer Letters. 479 (2020) - p. 89-99 , 2020
Link:
https://doi.org/10.1016/..
?
13
Cabozantinib in advanced renal cell carcinoma: A phase II, ..:
Tomita, Yoshihiko
;
Tatsugami, Katsunori
;
Nakaigawa, Noboru
...
International Journal of Urology. 27 (2020) 11 - p. 952-959 , 2020
Link:
https://doi.org/10.1111/..
?
14
Editorial Comment to Efficacy and safety of first‐line nivo..:
Tamada, Satoshi
International Journal of Urology. 27 (2020) 12 - p. 1100-1101 , 2020
Link:
https://doi.org/10.1111/..
?
15
Enzalutamide versus flutamide for castration-resistant pros..:
Iguchi, Taro
;
Tamada, Satoshi
;
Kato, Minoru
...
International Journal of Clinical Oncology. 25 (2019) 3 - p. 486-494 , 2019
Link:
https://doi.org/10.1007/..
1-15